Bristol-Myers Squibb (BMY)
$39.99
0.33 (0.83%)
BMY Stock Quote Delayed 30 Minutes
4 Pharmaceutical Stocks to Buy Now
The grades of four Pharmaceutical stocks are on the rise this week on Portfolio Grader. Each of these stocks is rated an "A" ("strong buy") or "B" overall ("buy").
Top 5 Stocks for 2024
INSIDE: Investing legend Louis Navellier reveals his Top 5 Stocks for 2024 — FREE!
Download His Free Report Here:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Unlock Louis Navellier's
? Stock Report – FREE:
Is ? a BUY?
Powered by Portfolio Grader
A
B
C
D
F
?
Unlock Louis Navellier's
? Stock Report to Find Out – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Investing legend Louis Navellier rates ? a "?." Unlock his ? Stock Analysis to find out why – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Fundamental Grade
Quantitative Grade
- Sales Growth ?
- Operating Margin Growth ?
- Earnings Growth ?
- Earnings Momentum ?
- Earnings Surprises ?
- Analyst Earnings Revisions ?
- Cash Flow ?
- Return on Equity ?
Previous Close
-
Market Cap
88.86B
PE Ratio
-12.90
EPS
-3.1
Volume (Avg. Vol.)
13.37M
Day's Range
$39.50 - $40.11
52-Week Range
$39.35 - $65.38
Dividend & Yield
$2.28 (5.70%)
BMY Stock Predictions, Articles, and Bristol-Myers Squibb News
4 Pharmaceutical Stocks to Buy Now
This week, four Pharmaceutical stocks are improving their overall rating on Portfolio Grader. Each of these rates an "A" ("strong buy") or "B" overall ("buy").
4 Pharmaceutical Stocks to Buy Now
Four Pharmaceutical stocks are moving up in their overall rating this week, according to the Portfolio Grader database. Every one of these is graded an "A" ("strong buy") or "B" overall ("buy").
3 Pharma Stocks Just Running in Place
Gobs of free cash flow doesn't mean a company is worth buying. Some companies, especially pharmaceuticals, just use cash to run in place.
5 Pharmaceutical Stocks to Buy Now
The grades of five Pharmaceutical stocks are better this week, according to the Portfolio Grader database. Every one of these stocks has an "A" ("strong buy") or "B" overall ("buy") rating.
4 Pharmaceutical Stocks to Buy Now
The grades of four Pharmaceutical stocks are better this week, according to the Portfolio Grader database. Every one of these stocks has an "A" ("strong buy") or "B" overall ("buy") rating.
4 Pharmaceutical Stocks to Buy Now
This week, four Pharmaceutical stocks are improving their overall ratings on Portfolio Grader. Each of these stocks is rated an "A" ("strong buy") or "B" overall ("buy").
4 Pharmaceutical Stocks to Buy Now
The grades of four Pharmaceutical stocks are better this week, according to the Portfolio Grader database. Every one of these stocks has an "A" ("strong buy") or "B" overall ("buy") rating.
4 Pharmaceutical Stocks to Buy Now
Four Pharmaceutical stocks are moving up in their overall rating this week, according to the Portfolio Grader database. Every one of these is graded an "A" ("strong buy") or "B" overall ("buy").
4 Pharmaceutical Stocks to Buy Now
Four Pharmaceutical stocks are moving up in their overall rating this week, according to the Portfolio Grader database. Every one of these is graded an "A" ("strong buy") or "B" overall ("buy").
4 Pharmaceutical Stocks to Buy Now
This week, four Pharmaceutical stocks are improving their overall ratings on Portfolio Grader. Each of these stocks is rated an "A" ("strong buy") or "B" overall ("buy").
4 Pharmaceutical Stocks to Buy Now
This week, four Pharmaceutical stocks are improving their overall ratings on Portfolio Grader. Each of these stocks is rated an "A" ("strong buy") or "B" overall ("buy").
5 Megatrend Plays Offering Big Payouts
Megatrend investments usually require years if not decades to play out, but these five particular stocks offer investors some sizable income for waiting.
4 Pharmaceutical Stocks to Buy Now
The grades of four Pharmaceutical stocks are better this week, according to the Portfolio Grader database. Every one of these stocks has an "A" ("strong buy") or "B" overall ("buy") rating.
4 Pharmaceutical Stocks to Buy Now
This week, four Pharmaceutical stocks are improving their overall rating on Portfolio Grader. Each of these rates an "A" ("strong buy") or "B" overall ("buy").
Who Wins When Oracle Loses?
Oracle posted a second straight quarter of top-line disappointment, and Wall Street acted out accordingly. But a couple of boardrooms were probably filled with smiling faces.
4 Pharmaceutical Stocks to Buy Now
The grades of four Pharmaceutical stocks are on the rise this week on Portfolio Grader. Each of these stocks is rated an "A" ("strong buy") or "B" overall ("buy").
4 Pharmaceutical Stocks to Buy Now
The grades of four Pharmaceutical stocks are better this week, according to the Portfolio Grader database. Every one of these stocks has an "A" ("strong buy") or "B" overall ("buy") rating.
4 High-Fliers That Could Crash-Land Soon
2013 has been a very good year for some high-profile companies. In fact, for a few of these stocks, this year has been a little too good.
4 Pharmaceutical Stocks to Buy Now
Four Pharmaceutical stocks are moving up in their overall rating this week, according to the Portfolio Grader database. Every one of these is graded an "A" ("strong buy") or "B" overall ("buy").
